PAP-α Antibodies

Santa Cruz Biotechnology offers a broad range of PAP-α monoclonal antibodies to support research needs. PAP-α monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). PAP-α (prostatic acid phosphatase) plays a crucial role in prostate cancer biology, serving as a biomarker for diagnosis and monitoring disease progression. Its enzymatic activity is involved in the regulation of phosphate levels in the prostate, making it significant in both normal physiology and pathological conditions. The study of PAP-α is essential for understanding prostate cancer mechanisms and developing targeted therapies. PAP-α research has led to significant discoveries in prostate cancer detection methods and treatment strategies. Understanding PAP-α expression patterns helps identify potential therapeutic targets and evaluate treatment effectiveness. PAP-α monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance prostate cancer research and contribute to improved patient outcomes.